Özlem Kaplan

485 total citations
48 papers, 324 citations indexed

About

Özlem Kaplan is a scholar working on Molecular Biology, Materials Chemistry and Biomaterials. According to data from OpenAlex, Özlem Kaplan has authored 48 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Materials Chemistry and 5 papers in Biomaterials. Recurrent topics in Özlem Kaplan's work include Nanoparticles: synthesis and applications (9 papers), RNA Interference and Gene Delivery (8 papers) and Phytochemistry and Bioactivity Studies (5 papers). Özlem Kaplan is often cited by papers focused on Nanoparticles: synthesis and applications (9 papers), RNA Interference and Gene Delivery (8 papers) and Phytochemistry and Bioactivity Studies (5 papers). Özlem Kaplan collaborates with scholars based in Türkiye, Austria and Myanmar. Özlem Kaplan's co-authors include İ̇sa Gökçe, Aykut Özgür, İbrahim Türkekul, Seçil Erden Tayhan, Sema Bilgin, Mehmet Koray Gök, Cemil Alkan, Kamber Demir, Mariana Blanco Massani and Patrick Knoll and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Public Health and Carbohydrate Polymers.

In The Last Decade

Özlem Kaplan

36 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özlem Kaplan Türkiye 10 99 94 44 37 32 48 324
Komgrit Eawsakul Thailand 12 63 0.6× 54 0.6× 53 1.2× 43 1.2× 29 0.9× 30 316
Liye Wang China 11 91 0.9× 58 0.6× 81 1.8× 31 0.8× 29 0.9× 26 317
Fahe Wang China 7 90 0.9× 74 0.8× 65 1.5× 60 1.6× 15 0.5× 10 323
Rekha Gahtori India 9 60 0.6× 95 1.0× 72 1.6× 81 2.2× 16 0.5× 16 296
Ashok Kumar Mandal Nepal 6 55 0.6× 109 1.2× 55 1.3× 37 1.0× 15 0.5× 10 288
Plamen Zagorchev Bulgaria 11 88 0.9× 32 0.3× 60 1.4× 37 1.0× 23 0.7× 46 339
Sung-Chul Hong South Korea 12 86 0.9× 46 0.5× 41 0.9× 34 0.9× 21 0.7× 22 408
Tian Yang China 8 72 0.7× 63 0.7× 27 0.6× 66 1.8× 13 0.4× 13 432
Arjunan Karuppaiah India 9 92 0.9× 57 0.6× 73 1.7× 94 2.5× 12 0.4× 22 279

Countries citing papers authored by Özlem Kaplan

Since Specialization
Citations

This map shows the geographic impact of Özlem Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özlem Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özlem Kaplan more than expected).

Fields of papers citing papers by Özlem Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özlem Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özlem Kaplan. The network helps show where Özlem Kaplan may publish in the future.

Co-authorship network of co-authors of Özlem Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Özlem Kaplan. A scholar is included among the top collaborators of Özlem Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özlem Kaplan. Özlem Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kaplan, Özlem, et al.. (2026). Nicotinic Acid–Modified Chitosan Nanoparticles for Enhanced Resveratrol Delivery and Anticancer Activity. Biopolymers. 117(2). e70085–e70085.
3.
Kaplan, Özlem, et al.. (2025). Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta‐analysis of efficacy and safety. Pediatric Allergy and Immunology. 36(6). e70132–e70132.
4.
Kaplan, Özlem, et al.. (2025). Dual targeting of HSP90 and BCL-2 in breast cancer cells using inhibitors BIIB021 and ABT-263. Breast Cancer Research and Treatment. 210(2). 493–506.
5.
Kaplan, Özlem, et al.. (2025). Improving physiological solubility and gene transfer efficiency of chitosan via 3-nitrobenzaldehyde and amino acid conjugation. International Journal of Biological Macromolecules. 323(Pt 1). 147117–147117. 3 indexed citations
6.
Kaplan, Özlem, et al.. (2025). Silane and amino acid functionalized PBAEs for enhanced gene Delivery: Synthesis, characterization, and transfection efficiency. Journal of Drug Delivery Science and Technology. 109. 106990–106990. 3 indexed citations
7.
Kaplan, Özlem, et al.. (2025). Maternal RSV vaccine: a systematic review and meta-analysis of immunogenicity and perinatal safety. Immunologic Research. 73(1). 177–177.
8.
Kaplan, Özlem, et al.. (2025). Redox-responsive lipoic acid-modified poly (β-amino ester) nanoparticles for enhanced gene delivery. Reactive and Functional Polymers. 214. 106318–106318. 6 indexed citations
9.
Kaplan, Özlem, et al.. (2025). Redox-Responsive and mucoadhesive nanoparticles: An overlooked synergy in modern drug delivery. European Polymer Journal. 243. 114475–114475.
10.
Kaplan, Özlem, et al.. (2024). Escherichia coli in the production of biopharmaceuticals. Biotechnology and Applied Biochemistry. 72(2). 528–541. 5 indexed citations
11.
Kaplan, Özlem, et al.. (2024). Thiolated layered double hydroxide-based nanoparticles: A study on mucoadhesiveness and cytotoxicity. Colloids and Surfaces A Physicochemical and Engineering Aspects. 704. 135461–135461. 7 indexed citations
12.
Kaplan, Özlem, et al.. (2024). Escherichia coli as a versatile cell factory: Advances and challenges in recombinant protein production. Protein Expression and Purification. 219. 106463–106463. 32 indexed citations
13.
Kaplan, Özlem, et al.. (2024). Evaluation of Anticancer and Antimicrobial Potentials of Tarantula cubensis Venom (Theranekron® D6). Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi. 17(3). 626–637.
14.
Kaplan, Özlem, et al.. (2024). Tricine-modified chitosan as a strategy for enhancing hydrophilicity and gene delivery. Carbohydrate Research. 547. 109326–109326. 9 indexed citations
15.
Kaplan, Özlem, et al.. (2024). Enhancing gene delivery efficiency with amphiphilic chitosan modified by myristic acid and tertiary amino groups. International Journal of Biological Macromolecules. 282(Pt 1). 136775–136775. 9 indexed citations
16.
Aykur, Mehmet, et al.. (2023). Efficacy of the greenly synthesized silver, copper, and nickel nanoparticles using Allium tuncelianum extract against Acanthamoeba castellanii. Journal of Drug Delivery Science and Technology. 89. 105013–105013. 5 indexed citations
17.
Kaplan, Özlem, et al.. (2023). Optimization Studies of Mg/Al-NO3 Layered Double Hydroxide Nanoparticles by Hydrothermal Treatment. DergiPark (Istanbul University). 5(3). 163–175. 1 indexed citations
18.
Kaplan, Özlem, et al.. (2023). Biosynthesis of Iron, Copper and Silver Nanoparticles Using Polygonum Cognatum and Tragopogon Porrifolius Extracts and Evaluation of Their Antimicrobial Potentials. SHILAP Revista de lepidopterología. 11(4). 2155–2167. 2 indexed citations
19.
Kaplan, Özlem. (2023). Synergistic induction of apoptosis in liver cancer cells: exploring the combined potential of doxorubicin and XL-888. Medical Oncology. 40(11). 318–318. 5 indexed citations
20.
Kaplan, Özlem, Gergely Kali, Patrick Knoll, et al.. (2023). Thiolated α-cyclodextrin: The likely smallest drug carrier providing enhanced cellular uptake and endosomal escape. Carbohydrate Polymers. 316. 121070–121070. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026